1.025USD-5.09%Mkt Cap: 66.33M USDP/E: —Last update: 2026-06-01
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product is…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap66.33M USD
Enterprise Value35.06M USD
Revenue (TTM)9.14M USD
Gross Profit-95.53M USD
Net Income (TTM)-129.77M USD
Revenue/Share0.1520 USD
Last Price1.025 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees138
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.22
PEG—
EV/EBITDA-0.28
EV/Revenue3.84
P/S7.73
P/B0.50
EPS (TTM)-0.96
EPS (Forward)-0.89
52W Range
0.88208% of range2.570
52W High2.570 USD
52W Low0.8820 USD
Profitability
Gross Margin0.00%
Oper. Margin-2967.31%
EBITDA Margin0.00%
Profit Margin-1256.81%
ROE-105.40%
ROA-56.72%
Growth
Revenue Growth-54.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-135.32M USD
CapEx (TTM)4.41M USD
FCF Margin-920.62%
FCF Yield-126.80%
Net Debt-35.52M USD
Net Debt/EBITDA0.29
Balance Sheet
Debt/Equity0.76
Current Ratio6.65
Quick Ratio6.41
Book Value/Sh2.164 USD
Cash/Share1.960 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)6.000 USD
Target Range5.000 USD – 7.000 USD
# Analysts4
Ownership
Shares Out.61.07M
Float55.39M
Insiders0.20%
Institutions59.47%
Short Interest
Short Ratio0.9d
Short % Float1.96%
Short % Out.1.34%
Shares Short876.56K
Short (prev mo.)942.88K
Technical
SMA 501.110 (-7.7%)
SMA 2001.326 (-22.7%)
Beta1.06
S&P 52W Chg27.70%
Avg Vol (30d)774.17K
Avg Vol (10d)497.73K
Technical Indicators
RSI (14)47.3
MACD-0.0261
MACD Signal-0.0237
MACD Hist.-0.0024
BB Upper1.304 USD
BB Middle1.116 USD
BB Lower0.9274 USD
BB Width33.79%
ATR (14)0.0764 USD
Vol Ratio (20d)0.24x